MORTON M. HALPERN, M.D.; LOUIS LEMBERG, M.D.; MARTIN BELLE, M.D.; HERBERT EICHERT, M.D., F.A.C.P.
Reliable evidence accumulated in the last 10 years has indicated that anticoagulants are of decided value in the prevention and treatment of thromboembolic diseases. Beginning with Wright's report in 1945,1 the specific value of anticoagulants in the management of acute myocardial infarction has been adequately demonstrated by many investigators.
The advisability of instituting anticoagulant therapy in every case of cardiac infarction has been challenged recently.2-5 Inconvenience, expense, and certain known hazards inherent in anticoagulant therapy were stated to outweigh any benefits that might accrue from its use in the so-called "good risk" cases. One report6 goes even further, by concluding
HALPERN MM, LEMBERG L, BELLE M, EICHERT H. THE SELECTIVE USE OF ANTICOAGULANTS IN ACUTE MYOCARDIAL INFARCTION BASED ON INITIAL PROGNOSIS1. Ann Intern Med. ;41:942–951. doi: 10.7326/0003-4819-41-5-942
Download citation file:
© 2018
Published: Ann Intern Med. 1954;41(5):942-951.
DOI: 10.7326/0003-4819-41-5-942
Acute Coronary Syndromes, Cardiology, Coronary Heart Disease, Emergency Medicine.
Results provided by: